A founding team combining FDA Breakthrough-track digital biomarker experience, two decades of pharma commercialisation, and production-grade multimodal ML engineering — supported by senior CNS-development advisors.
Applied Neuroscientist and Biomedical Engineer specializing in Digital Biomarkers since 1998. Founded VoRo (Computer Vision, acquired by Apple for $350M in 2013) and Altoida Inc (FDA Breakthrough Device designation 2021). Adjunct Professor at University of Michigan Medical School in Psychiatry. EIT 2018 innovator award and MIT Media Lab alumni 2025 for AI Ventures
Neuroengineer and AI researcher with 10+ years of experience at the intersection of cognitive neuroscience, computer vision, and machine learning. Former postdoctoral researcher at Tel Aviv University, leading work on non-invasive neurostimulation, closed-loop systems, and multimodal signal analysis. CTO and co-founder of multiple AI ventures, with hands-on ownership of platform architecture from research prototype to production-grade systems.
AI product leader at Google with 20+ years of experience building large-scale SaaS and AI systems, including semantic search platforms generating $200M+ in annual value. Launched multiple award-winning products and holds several patents. Previously held leadership roles at Care.com and McKinsey, focusing on AI, cybersecurity, M&A, and enterprise software strategy.
Physician executive with extensive experience in clinical strategy, program development, and healthcare innovation. Combines frontline medical expertise with strong business acumen (Executive MBA, MIT Sloan) and a track record of leading multidisciplinary initiatives in population health, digital care models, and evidence-based program design. Recognized for bridging clinical insight with scalable healthcare solutions and advancing innovation at system level.
For investor materials, technical briefs, or partnership discussions, see ↓
Contact us →
Board-certified neurologist; Director, New England Center for Neurology and Headache. Yale School of Medicine. Principal investigator on numerous CNS clinical trials.
Clinical neuropsychologist specializing in cognitive and neuropsychological assessment across aging, mild cognitive impairment, and neurodegenerative disease. Extensive experience developing and validating measures for CNS clinical research.
Professor and Chair of Computer Science at the University of Crete, and researcher at the Institute of Computer Science, FORTH. His group at FORTH leads the computer-vision analysis pipeline behind the Telephos platform.
Telephōs is built for federated, multi-site clinical research. We work alongside academic partners, hospital networks, and industry sponsors across Europe.